Dopamine Advantage – Support for mental clarity, motivation and dopamine balance

Summary
Dopamine Advantage is an advanced nutritional supplement designed to support the brain's dopamine balance, cognitive function and mental motivation. The formula combines a powerful plant extract from phellodendron (Amur cork tree) and an active form of vitamin B12 (adenosylcobalamin) which together can help inhibit the enzyme MAO-B and support healthy dopamine activity in the brain. This product has been specially developed for people who want to promote better concentration, focus, mental sharpness and mood in a natural and safe way.

Health benefits and effects

• Supports normal dopamine balance in the brain, which is essential for motivation, joy and mental energy

• Promotes cognitive function, including focus, attention and information processing

• Prevents the breakdown of dopamine through inhibition of the enzyme MAO-B

• Protects brain cells against oxidative stress with the help of vitamin B12 and phellodendron

• Can contribute to better mood and emotional stability by increasing available dopamine

• Especially beneficial for aging, when natural dopamine levels tend to drop

• Non-addictive and without stimulants, suitable for daily use

Technical specifications

• Recommended use: 1 capsule daily or as recommended by healthcare professionals

• Contents per capsule:

  • Vitamin B12 (as adenosylcobalamin): 500 mcg

  • Phellodendron (Amur cork tree) bark powder: 500 mg

• Other ingredients: Vegetable cellulose (capsule), microcrystalline cellulose, vegetable stearate, silica

• Number of capsules: 30 vegetable capsules

• Free for: Gluten, GMO, animal ingredients

• Product type: Dietary supplements

Mode of action and ingredient analysis

• Phellodendron bark powder (Amur cork tree): A plant source with documented neuroprotective properties. In research studies, the extract has shown the ability to inhibit monoamine oxidase-B (MAO-B), an enzyme that breaks down dopamine in the brain. By inhibiting MAO-B, phellodendron can contribute to increased dopamine levels and improved mental performance.

• Adenosylcobalamin (active form of vitamin B12): This form of B12 is neurologically active and can cross the blood-brain barrier. It participates in energy production in the mitochondria and helps to protect neurons against oxidative stress. Studies have also shown that adenosylcobalamin can modulate the activity of the enzyme LRRK2, which regulates dopamine signaling.

Reservation
Allowed to be used by adults. All use of supplements is at your own risk and should be done in consultation with a doctor.
The recommended daily dose should not be exceeded.
The effect of this product may vary from person to person.
Dietary supplements should not replace a varied diet.
Should be kept out of the reach of children.
Uno Vita AS does not claim that the products we market can cure disease.

Disclaimer
Uno Vita increasingly uses artificial intelligence for analyses, summaries and design of articles. We do not accept responsibility for possible errors in texts, articles or descriptions due to human or computer technology (AI) errors, inaccuracies or missing information in scientific and medical studies.
We encourage all readers to examine all information critically to ensure that the content is correct. Uno Vita does not claim medical effects of the products we sell, but we refer to publicly available research in accordance with the right to freedom of expression. The information on this website is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis or treatment. The content must not be used as a basis for making diagnoses or choosing forms of treatment. All information and materials on this website are provided "as is" without any warranties, either expressed or implied, including, but not limited to, implied warranties of merchantability, fitness for a particular purpose or non-infringement.
Uno Vita disclaims all responsibility for loss or damage that may arise as a result of the use of information or products from this website. We strongly recommend that you consult a qualified healthcare professional before starting any new treatment, dietary change or use of supplements. Any use of products or information from this website is at your own risk.

Freedom of expression and right to information
Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like.
We do this with reference to national and international laws on freedom of expression and belief, including:

• United Nations Universal Declaration of Human Rights (1948), Article 19

• International Covenant on Civil and Political Rights (1966), Article 19

• Section 100 of the Norwegian Constitution

• America's First Amendment
  Uno Vita reserves the right to freedom of opinion and expression in line with these principles.

Scientific references

1. Cho SH et al. Screening of natural product extracts for MAO-B inhibition. Arch Pharm Res. 2016.

2. Watanabe F et al. Vitamin B12 active coenzyme forms in the brain. Int J Mol Sci. 2013.

3. Zawada WM et al. Role of LRRK2 in dopaminergic neuron protection. Neurobiol Dis. 2015.

4. Obata T. MAO inhibitors and their role in the treatment of neurological diseases. Neurochem Int. 2002.

5. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006.

6. Kang SS et al. LRRK2 modulates dopaminergic neurotransmission. J Neurosci. 2012.

7. Banerjee R. Vitamin B12: Chemistry and biochemistry. Chem Rev. 1999.

8. Halaris A. Inflammation, heart disease, and depression. Curr Psychiatry Rep. 2013.

9. Schousboe A et al. Glial modulation of neurotransmission. Cell Mol Neurobiol. 2004.

10. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998.

11. Olanow CW et al. Dopaminergic neurodegeneration in Parkinson's disease. Ann Neurol. 2003.

12. Jahanshahi M et al. The role of dopamine in cognition. Brain. 2000.

13. Tzschentke TM. Pharmacology and behavioral neuroscience of the mesocortical dopamine system. Prog Neurobiol. 2001.

14. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by precursor availability. Science. 1971.

15. Blum K et al. Neurogenetics and dopaminergic modulation in reward deficiency syndrome. J Psychiatr Res. 2014.

16. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1987.

17. Amenta F, Tayebati SK. Pathways of aging and neuroprotection. Curr Med Chem. 2008.

18. Kelley BJ, Petersen RC. Alzheimer's disease and mild cognitive impairment. Neurol Clin. 2007.

19. Fahn S. The medical treatment of Parkinson's disease. J Neural Transm Suppl. 2006.

20. Lieberman JA. Dopamine partial agonists: new developments. Am J Psychiatry. 2004.

21. Yamada M, Yasuhara H. MAO inhibitors in neurological diseases. Curr Med Chem. 2004.